Gida » Duka » Hasashen Hannun Jari » Tarsus Pharmaceuticals Inc. Common Stock Hasashen

Tarsus Pharmaceuticals Inc. Common Stock Hasashen: Gobe, Mako, Watan, Shekaru 5

An sabunta: April 22 · 2026 at 07:03 UTC

From

▼ -2.21%Market Cap $2.75B · Technical analysis Bearish · Focus area Price + volatility

Takaitaccen Hasashen

Lokaci	Farashin Hasashen	Baya	Na tarihi	Hankali
Gobe	$63.83 ▼ -1.06%	Jiya	$64.80 ▲ +0.45%	Tomorrow's Tarsus Pharmaceuticals Inc. Common Stock (TARS) setup is anchored to $64.51 and targets $63.83 (-1.06%). The near-term read is downside; watch $66.45 / $62.57 because daily realized volatility is about 5.47%.
Tomorrow's Tarsus Pharmaceuticals Inc. Common Stock (TARS) setup is anchored to $64.51 and targets $63.83 (-1.06%). The near-term read is downside; watch $66.45 / $62.57 because daily realized volatility is about 5.47%.
Mako	$62.38 ▼ -3.30%	Makon da ya gabata	$65.40 ▲ +1.39%	The 7-day Tarsus Pharmaceuticals Inc. Common Stock model moves from $65.40 to $62.38 (-3.30%). It gives downside momentum context for this stock, so breaks around $66.45 / $62.57 matter more than a single tick.
The 7-day Tarsus Pharmaceuticals Inc. Common Stock model moves from $65.40 to $62.38 (-3.30%). It gives downside momentum context for this stock, so breaks around $66.45 / $62.57 matter more than a single tick.
Watan	$59.98 ▼ -7.03%	A watan da ya gabata	$66.41 ▲ +2.95%	The 1-month Tarsus Pharmaceuticals Inc. Common Stock target is $59.98 (-7.03%), compared with the live reference near $64.51. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Tarsus Pharmaceuticals Inc. Common Stock target is $59.98 (-7.03%), compared with the live reference near $64.51. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Shekara	$56.37 ▼ -12.62%	Shekaran da ya gabata	$67.93 ▲ +5.30%	The 1-year Tarsus Pharmaceuticals Inc. Common Stock scenario points to $56.37 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Tarsus Pharmaceuticals Inc. Common Stock scenario points to $56.37 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
Shekaru 5	$47.92 ▼ -25.71%	Shekaru 5 da suka gabata	$71.48 ▲ +10.80%	The 5-year Tarsus Pharmaceuticals Inc. Common Stock view is $47.92 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Tarsus Pharmaceuticals Inc. Common Stock view is $47.92 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Gobe$63.83▼ -1.06%

Jiya$64.80▲ +0.45%

Tomorrow's Tarsus Pharmaceuticals Inc. Common Stock (TARS) setup is anchored to $64.51 and targets $63.83 (-1.06%). The near-term read is downside; watch $66.45 / $62.57 because daily realized volatility is about 5.47%.

Mako$62.38▼ -3.30%

Makon da ya gabata$65.40▲ +1.39%

The 7-day Tarsus Pharmaceuticals Inc. Common Stock model moves from $65.40 to $62.38 (-3.30%). It gives downside momentum context for this stock, so breaks around $66.45 / $62.57 matter more than a single tick.

Watan$59.98▼ -7.03%

A watan da ya gabata$66.41▲ +2.95%

The 1-month Tarsus Pharmaceuticals Inc. Common Stock target is $59.98 (-7.03%), compared with the live reference near $64.51. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Shekara$56.37▼ -12.62%

Shekaran da ya gabata$67.93▲ +5.30%

The 1-year Tarsus Pharmaceuticals Inc. Common Stock scenario points to $56.37 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

Shekaru 5$47.92▼ -25.71%

Shekaru 5 da suka gabata$71.48▲ +10.80%

The 5-year Tarsus Pharmaceuticals Inc. Common Stock view is $47.92 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Jadawalin farashi

Na tarihiHasashenTsananiBearish

Binciken Fasaha

Bearish

Tsanani

tsaka tsaki

Bearish

Maɓallin Maɓalli

Mai nuna alama	Daraja	Sigina
Price	$64.51	Mid
Daily Change	-2.21%	Below
Volatility Cap	20.0%	Mid
Confidence	62%	Below
Data Source	nasdaq-screener	Mid

Bayanan Tarihi

Current$64.51

Daily Change-2.21%

Market Cap$2.75B

Sourcenasdaq-screener

Current	$64.51	Daily Change	-2.21%
Market Cap	$2.75B	Source	nasdaq-screener

Taimako & Matakan Juriya

$62.57Support 1

$64.51A halin yanzu

$66.45Resistance 1

shield

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Matsalolin Farashi

Mahimmin matakai & mahallin tarihi

Current$64.51Live reference price

Used as the anchor for generated forecast calculations.

Next Month$59.98Model projection-7.03%

Directional scenario based on capped drift.

Daidaiton Hasashen

Yadda samfurin mu ya yi

62%

Jagoranci

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Algorithm ɗin mu ana sake daidaita shi mako-mako ta amfani da sabon aikin farashi, tsarin canji, da sigina masu nuni. Daidaito ya bambanta ta hanyar lokaci - gajeren lokaci yana da aminci fiye da tsinkaya na dogon lokaci.

Short term

62%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Yanayin Zuba Jari

Idan kun saka $1,000 a cikin TARS a yau

Bullish Scenario

$67.74

+5.00% from current

Farashin Target$67.74

Halin yanayiUpside momentum

Yiwuwa54%

Base Scenario

$59.98

-7.03%

Farashin Target$59.98

Halin yanayiCapped drift

Yiwuwa62%

Bearish Scenario

$61.28

-5.00% from current

Farashin Target$61.28

Halin yanayiVolatility drawdown

Yiwuwa38%

Tushen: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Abubuwan Hasashen

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bearish · 35/100

24H drift-1.06%

7D drift-3.30%

30D drift-7.03%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-Off Caution · 27/100

1M outlook-7.03%

1Y outlook-12.62%

5Y outlook-25.71%

Tambayoyin da ake yawan yi

Q What is the Tarsus Pharmaceuticals Inc. Common Stock (TARS) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Tarsus Pharmaceuticals Inc. Common Stock is projected near $63.83 versus the current reference around $64.51. That implies a modeled move of -1.06% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for TARS?

The weekly Tarsus Pharmaceuticals Inc. Common Stock model points to $62.38, which maps to an expected drift of -3.30% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Tarsus Pharmaceuticals Inc. Common Stock 1-month and 1-year targets?

The Tarsus Pharmaceuticals Inc. Common Stock 1-month target is $59.98 (-7.03%), while the 1-year target is $56.37 (-12.62%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Tarsus Pharmaceuticals Inc. Common Stock 5-year scenario differ from short-term rows?

The Tarsus Pharmaceuticals Inc. Common Stock long-horizon scenario sits near $47.92 with a modeled change of -25.71%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are TARS support and resistance zones right now?

For Tarsus Pharmaceuticals Inc. Common Stock, nearest resistance is around $62.57, while nearest support is around $66.45. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Tarsus Pharmaceuticals Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.